Robert Gornall

Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials

Ignace Vergote, Corneel Coens, Matthew Nankivell et al. · The Lancet Oncology · 2018 · 290 citations · Full text

Surgical Oncology, Gynecological Surgery, Individual Patient Data +10

Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer—A clinical and pathological evaluation

Martin August Voss, Raji Ganesan, Linmarie Ludeman et al. · Gynecologic Oncology · 2011 · 151 citations

Tumoral Pathology, Pathological Evaluation, Medicine +6

Predictors of complications in gynaecological oncological surgery: a prospective multicentre study (UKGOSOC—UK gynaecological oncology surgical outcomes and complications)

R. Rajagopalan Iyer, A. Gentry-Maharaj, A Nordin et al. · British Journal of Cancer · 2014 · 63 citations · Full text

Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer

Martin August Voss, Naheema S. Gordon, Stephanie Louise Maloney et al. · British Journal of Cancer · 2011 · 63 citations · Full text

Is conservative treatment for adenocarcinoma <i><b>in situ</b></i> of the cervix safe?

W. P. Soutter, Dimitrios Haidopoulos, Robert Gornall et al. · BJOG An International Journal of Obstetrics & Gynaecology · 2001 · 55 citations